VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage hodgkin's disease: Results of a prospective clinical trial

Sarah S. Donaldson, Melissa M. Hudson, Kathleen R. Lamborn, Michael P. Link, Larry Kun, Amy Louise Billett, Karen C. Marcus, Craig A. Hurwitz, Jeffrey A. Young, Nancy J. Tarbell, Howard J. Weinstein